IL183191A0 - N-[(3s)-pyrrolidin-3-yl]-benzamide derivatives as monoamine re-uptake inhibitors - Google Patents
N-[(3s)-pyrrolidin-3-yl]-benzamide derivatives as monoamine re-uptake inhibitorsInfo
- Publication number
- IL183191A0 IL183191A0 IL183191A IL18319107A IL183191A0 IL 183191 A0 IL183191 A0 IL 183191A0 IL 183191 A IL183191 A IL 183191A IL 18319107 A IL18319107 A IL 18319107A IL 183191 A0 IL183191 A0 IL 183191A0
- Authority
- IL
- Israel
- Prior art keywords
- monoamine
- pyrrolidin
- uptake inhibitors
- benzamide derivatives
- benzamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0425766.3A GB0425766D0 (en) | 2004-11-23 | 2004-11-23 | Novel compounds |
PCT/IB2005/003643 WO2006056884A1 (en) | 2004-11-23 | 2005-11-18 | N- [ (3s)- pyrrolidin-3-yl]- benzamide derivatives as monoamine re-uptake inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL183191A0 true IL183191A0 (en) | 2007-08-19 |
Family
ID=33548739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL183191A IL183191A0 (en) | 2004-11-23 | 2007-05-14 | N-[(3s)-pyrrolidin-3-yl]-benzamide derivatives as monoamine re-uptake inhibitors |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP1817281A1 (nl) |
JP (1) | JP4233596B2 (nl) |
KR (1) | KR100886294B1 (nl) |
CN (1) | CN101065355A (nl) |
AP (1) | AP2007004003A0 (nl) |
AR (1) | AR052243A1 (nl) |
AU (1) | AU2005308534A1 (nl) |
BR (1) | BRPI0518486A2 (nl) |
CA (1) | CA2589258A1 (nl) |
CR (1) | CR9171A (nl) |
EA (1) | EA011217B1 (nl) |
GB (1) | GB0425766D0 (nl) |
GT (1) | GT200500337A (nl) |
IL (1) | IL183191A0 (nl) |
MA (1) | MA29038B1 (nl) |
MX (1) | MX2007006138A (nl) |
NL (2) | NL1030485C2 (nl) |
NO (1) | NO20072486L (nl) |
PA (1) | PA8653501A1 (nl) |
PE (1) | PE20061056A1 (nl) |
SV (1) | SV2006002311A (nl) |
TN (1) | TNSN07201A1 (nl) |
TW (1) | TWI300776B (nl) |
UY (1) | UY29224A1 (nl) |
WO (1) | WO2006056884A1 (nl) |
ZA (1) | ZA200703910B (nl) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH628885A5 (en) * | 1978-01-01 | 1982-03-31 | Anphar Sa | Piperidine derivative |
AP2005003467A0 (en) * | 2003-06-17 | 2006-12-31 | Pfizer | N-pyrrolidin-3-YL-amide derivatives as serotonin and noradrenaline reuptake inhibitors. |
GB0314054D0 (en) * | 2003-06-17 | 2003-07-23 | Pfizer Ltd | Amide derivatives as selective serotonin re-uptake inhibitors |
-
2004
- 2004-11-23 GB GBGB0425766.3A patent/GB0425766D0/en not_active Ceased
-
2005
- 2005-11-18 KR KR1020077014351A patent/KR100886294B1/ko not_active IP Right Cessation
- 2005-11-18 CN CNA2005800401025A patent/CN101065355A/zh active Pending
- 2005-11-18 JP JP2007542360A patent/JP4233596B2/ja not_active Expired - Fee Related
- 2005-11-18 WO PCT/IB2005/003643 patent/WO2006056884A1/en active Application Filing
- 2005-11-18 MX MX2007006138A patent/MX2007006138A/es active IP Right Grant
- 2005-11-18 AP AP2007004003A patent/AP2007004003A0/xx unknown
- 2005-11-18 BR BRPI0518486-0A patent/BRPI0518486A2/pt not_active IP Right Cessation
- 2005-11-18 CA CA002589258A patent/CA2589258A1/en not_active Abandoned
- 2005-11-18 AU AU2005308534A patent/AU2005308534A1/en not_active Abandoned
- 2005-11-18 EP EP05808510A patent/EP1817281A1/en not_active Withdrawn
- 2005-11-18 EA EA200700920A patent/EA011217B1/ru not_active IP Right Cessation
- 2005-11-21 PE PE2005001362A patent/PE20061056A1/es not_active Application Discontinuation
- 2005-11-21 AR ARP050104866A patent/AR052243A1/es not_active Application Discontinuation
- 2005-11-22 NL NL1030485A patent/NL1030485C2/nl not_active IP Right Cessation
- 2005-11-22 TW TW094140922A patent/TWI300776B/zh active
- 2005-11-22 GT GT200500337A patent/GT200500337A/es unknown
- 2005-11-22 UY UY29224A patent/UY29224A1/es not_active Application Discontinuation
- 2005-11-23 SV SV2005002311A patent/SV2006002311A/es unknown
- 2005-11-23 PA PA20058653501A patent/PA8653501A1/es unknown
-
2006
- 2006-10-27 NL NL1032760A patent/NL1032760C2/nl not_active IP Right Cessation
-
2007
- 2007-05-14 IL IL183191A patent/IL183191A0/en unknown
- 2007-05-15 ZA ZA200703910A patent/ZA200703910B/xx unknown
- 2007-05-15 NO NO20072486A patent/NO20072486L/no not_active Application Discontinuation
- 2007-05-22 TN TNP2007000201A patent/TNSN07201A1/fr unknown
- 2007-05-23 MA MA29935A patent/MA29038B1/fr unknown
- 2007-06-07 CR CR9171A patent/CR9171A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20070086599A (ko) | 2007-08-27 |
EA011217B1 (ru) | 2009-02-27 |
NO20072486L (no) | 2007-06-20 |
AU2005308534A1 (en) | 2006-06-01 |
AP2007004003A0 (en) | 2007-06-30 |
GB0425766D0 (en) | 2004-12-22 |
KR100886294B1 (ko) | 2009-03-04 |
BRPI0518486A2 (pt) | 2008-11-18 |
CN101065355A (zh) | 2007-10-31 |
ZA200703910B (en) | 2008-09-25 |
TNSN07201A1 (fr) | 2008-11-21 |
GT200500337A (es) | 2006-06-13 |
PA8653501A1 (es) | 2006-06-02 |
CR9171A (es) | 2007-07-04 |
WO2006056884A1 (en) | 2006-06-01 |
JP2008520646A (ja) | 2008-06-19 |
UY29224A1 (es) | 2006-06-30 |
JP4233596B2 (ja) | 2009-03-04 |
EP1817281A1 (en) | 2007-08-15 |
TW200626543A (en) | 2006-08-01 |
EA200700920A1 (ru) | 2007-12-28 |
NL1032760A1 (nl) | 2006-12-13 |
NL1030485C2 (nl) | 2006-11-07 |
NL1030485A1 (nl) | 2006-05-24 |
NL1032760C2 (nl) | 2007-04-17 |
AR052243A1 (es) | 2007-03-07 |
CA2589258A1 (en) | 2006-06-01 |
MX2007006138A (es) | 2007-07-19 |
MA29038B1 (fr) | 2007-11-01 |
TWI300776B (en) | 2008-09-11 |
SV2006002311A (es) | 2006-09-14 |
PE20061056A1 (es) | 2006-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20130810T1 (en) | Sulphonylpyrroles as hdac inhibitors | |
EP1756092A4 (en) | NEW INHIBITORS OF RHO-KINASEN | |
HK1099300A1 (en) | Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors | |
ZA200802585B (en) | Pyridopyrimidinone inhibitors of Pl3Kα | |
IL190292A0 (en) | PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka | |
ZA200610593B (en) | Diphenylimidazopyrimidine and -imidazole amines as inhibitors of ß-secretase | |
ZA200706345B (en) | Amino-pyridines as inhibitors of ß-secretase | |
ZA200801394B (en) | Novel sulphonylpyrroles as inhibitors of HDAC S novel sulphonylpyrroles | |
ZA200608221B (en) | Thiadlazolidinones as GSK-3 Inhibitors | |
IL179371A0 (en) | 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor | |
IL191035A0 (en) | Pharmaceutical use of substituted amides | |
IL191034A0 (en) | Pharmaceutical use of substituted amides | |
HK1193094A1 (zh) | 可用作單胺再攝取抑制劑的 -取代的 -氨基吡咯烷化合物 | |
HK1108283A1 (en) | Alkil-pyridines as 11-beta inhibitors for diabetes | |
EP1957474A4 (en) | SYNTHESIS OF FTFZ INHIBITORS | |
GB0314054D0 (en) | Amide derivatives as selective serotonin re-uptake inhibitors | |
ATE383335T1 (de) | 3-amino-pyrrolidine als inhibitoren der monoamin- wiederaufnahme | |
GB0501146D0 (en) | Novel benzamide derivatives | |
IL178734A0 (en) | Novel alkyl substituted piperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
EP1912662A4 (en) | PEPTIDE DEFORMYLASE INHIBITORS | |
IL180777A0 (en) | Novel chromen-2- one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
IL183191A0 (en) | N-[(3s)-pyrrolidin-3-yl]-benzamide derivatives as monoamine re-uptake inhibitors | |
EP1924275A4 (en) | INHIBITORS CONTAINING THIO COMPOUND OF AMINOPEPTIDASE P, THEIR COMPOSITIONS AND METHOD OF USE | |
GB0526351D0 (en) | Novel benzamide derivatives | |
ZA200701615B (en) | Novel chromen-2-one derivatives and their use as monoamine neutrotransmitter re-uptake inhibitors |